Cargando…

Evaluation of intravenous voriconazole in patients with compromised renal function

BACKGROUND: Incorporation of the solubilizing excipient, sulfobutylether-β-cyclodextrin (SBECD), in the intravenous (IV) formulation of voriconazole has resulted in the recommendation that this formulation be used with caution in patients with creatinine clearances (Cl(cr)) < 50 mL/min. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lilly, Craig M, Welch, Verna L, Mayer, Thomas, Ranauro, Paul, Meisner, Joanne, Luke, David R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584958/ https://www.ncbi.nlm.nih.gov/pubmed/23320795 http://dx.doi.org/10.1186/1471-2334-13-14

Ejemplares similares

Evaluation of the Interaction of Intravenous and Oral Voriconazole with Oral Cyclosporine in Iranian HSCT Patients
por: Masoumi, Hamidreza Taghvaye, et al.
Publicado: (2017)

Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
por: Honore, Patrick M, et al.
Publicado: (2015)

Intravenous Drug Use-Associated Scopulariopsis Endophthalmitis Treated with Systemic and Intravitreal Voriconazole
por: Raevis, Joseph J., et al.
Publicado: (2018)

Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
por: Cho, Sang-Heon, et al.
Publicado: (2020)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
por: Liang, Zaiming, et al.
Publicado: (2022)

Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy
por: von Mach, Marc A, et al.
Publicado: (2006)

Amphotericin-B-liposomal/voriconazole: Renal impairment: case report
Publicado: (2021)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Pharmacokinetics and safety of two Voriconazole formulations after intravenous infusion in two doses in healthy Chinese subjects
por: Li, Xin, et al.
Publicado: (2023)

Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
por: Li, Zi-Wei, et al.
Publicado: (2017)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity
por: Veloso, Danillo F. M. C., et al.
Publicado: (2018)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis
por: Malhotra, Sakshi, et al.
Publicado: (2014)

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
por: Cheng, Lin, et al.
Publicado: (2023)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

1733. Voriconazole Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplant: How Much Is Enough, Are Low Voriconazole Levels Associated With Opportunistic Infections, and What Are the Reasons for Discontinuation?
por: Hadjivassiliou, Giorgos, et al.
Publicado: (2019)

Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole
por: Nazik, Hasan, et al.
Publicado: (2017)

Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel
por: Pandurangan, Dinesh Kumar, et al.
Publicado: (2016)

Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application
por: Khare, Anubha, et al.
Publicado: (2016)

Successful treatment of Chrysosporium keratitis with voriconazole
por: Thanathanee, Onsiri, et al.
Publicado: (2017)

Comparison of clinical pharmacology of voriconazole and posaconazole
por: Sienkiewicz, Beata M., et al.
Publicado: (2016)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

Pharmacogenetic Analysis of Voriconazole Treatment in Children
por: Tilen, Romy, et al.
Publicado: (2022)

Impacto y expectativas de comunicación en salud con adolescentes : /
por: Ranauro García, Martha
Publicado: (2005)

Airway compromise following contrast extravasation from an external jugular intravenous line
por: McDonald, Jennifer S., et al.
Publicado: (2023)

Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy
por: Kiser, Tyree H, et al.
Publicado: (2015)

Software for Dosage Individualization of Voriconazole: a Prospective Clinical Study
por: Hope, William, et al.
Publicado: (2019)

Protein-energy malnutrition during early gestation in sheep blunts fetal renal vascular and nephron development and compromises adult renal function
por: Lloyd, Louise J, et al.
Publicado: (2012)

Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies
por: El-Emam, Ghada Ahmed, et al.
Publicado: (2020)

Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity
por: Farooq, Mudassir, et al.
Publicado: (2022)

Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases
por: Shen, Kunlu, et al.
Publicado: (2022)

Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial
por: Mootsikapun, Piroon, et al.
Publicado: (2013)

Update on the treatment of disseminated fusariosis: Focus on voriconazole
por: Stanzani, Marta, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p9c1cjil2mqhu6oduur0vj0fhf